Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease

Evidence-based Complementary and Alternative Medicine

Volumn 4, Issue 1, 2007, Pages 43-50

  Nakhai, Leila Ashtaral ^a   Mohammadirad, Azadeh ^a   Yasa, Narges ^b   Minaie, Bagher ^c   Nikfar, Shekoufeh ^a   Ghazanfari, Ghazal ^a   Zamani, Mohammad Jafar ^a   Dehghan, Gholamreza ^a   Jamshidi, Hamidreza ^a   Boushehri, Vahid Shetab ^a   Khorasani, Reza ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Cells lipid peroxidation; Inflammatory bowel disease; Myeloperoxidase; Rat; Zataria

Indexed keywords

ACETIC ACID; MYELOPEROXIDASE; PLANT EXTRACT; PREDNISOLONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; ZATARIA MULTIFLORA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENCY; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; LIPID PEROXIDATION; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; ZATARIA MULTIFLORA;

EID: 33947149124     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nel051     Document Type: Article

References (64)

1. Simmonds NJ, Rampton DS. Inflammatory bowel disease - a radical view. Gut 1993;34:865-8.
2. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86.
3. Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaiee A. Pesticides and oxidative stress: a review. Med Sci Monit 2004;10:RA144-7.
4. Nielsen OH, Ahnfelt-Ronne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991;69:995-1000.
5. Barbosa DS, Cecchini REl, Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 2003;19:837-42.
6. Hirayama A, Nagase S, Ueda A, Ishizu T, Taru Y, Yoh K, et al. Oxidative stress during leukocyte absorption apheresis. J Clin Apher 2003;18:61-6.
7. Ahnfelt-Ronne I, Nielsen OH. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 1987;21:191-4.
8. Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 2004;49:1752-7.
9. D'Odorico A, Bortolan S, Cardin R, D'Inca' R, Martines D, Ferronato A, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001;36:1289-94.
10. Krawisz JE, Sharon P, Stenson WF. Qualitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984;87:1344-50.
11. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
12. Hernandez-Perez M, Rabanal RM, de la Torre MC, Rodriguez B. Analgesic, anti-inflammatory, antipyretic and haematological effects of aethiopinone, an o-naphthoquinone diterpenoid from Salvia aethiopis roots and two hemisynthetic derivatives. Planta Med 1995;61:505-9.
13. Cuppett SL. Hall CA 3rd. Antioxidant activity of the Labiatae. Adv Food Nutr Res 1998;42:245-71.
14. Wasser S, Ho JM, Ang HK, Tan CE. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J Hepatol 1998;29:760-71.
15. Hosseinzadeh H, Haddad Khodaparast MH, Shokohizadeh H. Antihyperglycemic effect of Saliva leriifolia leaf and seed extract in mice. Irn J Med Sci 1998;23:78-80.
16. Zargari A. Medicinal Plants, 4th edn. Tehran: Tehran University Press, 1-57.
17. Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 2004;90:195-204.
18. Satho K. Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 1978;90:37-43.
19. Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 2004;69:4-9.
20. Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats. Gastroenteroloogy 1985;88:55-63.
21. Elson CO, Cong Y, Brandwein S, Weaver CT, McCabe RP, Mahler M, et al. Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann N Y Acad Sci 1998;859:85-95.
22. MacPherson B, Pfeiffer CJ. Experimental colitis. Digestion 1976;14:424-52.
23. Katzung BG. Basic & Clinical Pharmacology, 8th edn. New York. Appleton & Lange, 2000.
24. Hosseinzadeh H, Ramezani M, Salmani GA. Antinociceptive, antiinflammatory and acute toxicity effects of Zataria multiflora Boiss extracts in mice and rats. J Ethnopharmacol 2000;73:379-85.
25. Ramezani M, Hosseinzadeh H, Samizadeh S. Antinociceptive effects of Zataria multiflora Boiss fractions in mice. J Ethnopharmacol 2004;91:167-70.
26. Jaffary F, Ghannadi A, Siahpoush A. Antinociceptive effects of hydroalcoholic extract and essential oil of Zataria multiflora. Fitoterapia 2004;75:217-20.
27. Shafiee A, Javidnia K. Composition of essential oil of Zataria multiflora. Planta Med 1997;63:371-2.
28. Ebrahimzadeh H, Yamini Y, Sefidkon F, Chaloosi M, Pourmortazavi SM. Chemical composition of the essential oil and supercritical CO2 extracts of Zataria multiflora Boiss. Food Chem 2003;83:357-61.
29. Mohagheghzadeh A, Shams-Ardakani M, Ghannadi A. Volatile constituents of callus and flower-bearing tops of Zataria multiflora Boiss (Lamiaceae). Flavour Fragr J 2000;15:373-6.
30. Shaiq Ali M, Jahangir M, Saleem M, Uddin Ahmad V. Chemical constituents of Pulicaria gnaphalodes. Nat Prod Sci 1999;5:134-7.
31. Martinez-Vazquez M, Ramirez Apan TO, Aguilar H, Bye R. Analgesic and antipyretic activities of an aqueous extract and of the flavone linarin of Buddleia cordata. Planta Med 1996;62:137-40.
32. Ramesh M, Rao YN, Rao AV, Prabhakar MC, Rao CS, Muralidhar N, et al. Antinociceptive and anti-inflammatory activity of a flavonoid isolated from Caralluma attenuata. J Ethnopharmacol 1998;62:63-6.
33. Kim JA, Kim DK, Kang OH, Choi YA, Park HJ, Choi SC, et al. Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. Int Immunopharmacol 2005;5:209-17.
34. Parnham MJ, Kesselring K. Rosmarinic acid. Drugs Future 1985;10:756-7.
35. Mohagheghzadeh A, Shams-Ardakani M, Ghannadi A, Minaeian M. Rosmarinic acid from Zataria multiflora tops and in vitro cultures. Fitoterapia 2004;75:315-21.
36. Osakabe N, Yasuda A, Natsume M, Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 2004;25:549-57.
37. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-33.
38. Tuzun A, Erdil A, Inal V, Aydin A, Bagci S, Yesilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002;35:569-72.
39. McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996;98:136-41.
40. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859-61.
41. Allgayer H. Clinical relevance of oxygen radicals in inflammatory bowel disease - facts and fashion. Klin Wochenschr 1991;69:1001-3.
42. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S-15S.
43. Koutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 2004;49:1433-7.
44. Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003;201:17-27.
45. Le Marchand L. Cancer preventive effects of flavonoids - a review. Biomed Pharmacother 2002;56:296-301.
46. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-67S.
47. Sanchez de Medina F, Vera B, Galvez J, Zarzuelo A. Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci 2002;70:3097-108.
48. Hong T, Jin GB, Cho S, Cyong JC. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med 2002;68:268-71.
49. Villegas I, Alarcon de la Lastra C, Orjales A, La Casa C. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. Int Immunopharmacol 2003;l3:1731-41.
50. Abdollahi M, Chan TS, Subrahmanyam V, O'Brien PJ. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem 2003;252:205-11.
51. Abdollahi M, Bahreini-Moghadam A, Emami B, Fooladian F, Zafari K. Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comp Biochem Physiol C Toxicol Pharmacol 2003;135:331-6.
52. Abdollahi M, Fooladian F, Emami B, Zafari K, Bahreini-Moghadam A. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum Exp Toxicol 2003;22:587-92.
53. Aghababaeian R, Ghazi-Khansari M, Abdi K, Taghadosinejad F, Abdollahi M. Protective effects of sildenafil and dipyridamol from lead-induced lipid peroxidation in perfused rat liver. Intl J Pharmacol 2005;1:157-60.
54. Milani E, Nikfar S, Khorasani R, Zamani MJ, Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 2005;140:251-5.
55. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, doubleblind placebo-controlled clinical trial. Biomed Pharmacother 2005;59:302-6.
56. Zamani MJ, Sharifzadeh M, Rezaie A, Mashayekhi F, Abdollahi M. Effects of sildenafil on rat irritable bowel syndrome. Therapy 2005;2:237-42.
57. Saleem M, Nazli R, Afza N, Sami A, Ali MS. Biological significance of essential oil of Zataria multiflora boiss. Nat Prod Res 2004;18:493-7.
58. Rasooli I, Rezaei MB. Bioactivity and chemical properties of essential oils from Zataria multiflora Boiss and Mentha longifolia (L.) Huds. J Essent Oil Res 2002;14:141-6.
59. Basti AA, Razavilar V, Misaghi A, Radmehr B, Abbasifar R, Yazdani D, et al. Effect of Zataria multiflora Boiss. essential oil on probability of growth initiation of Staphylococcus aureus in a brain heart infusion broth. J Med Plants 2004;3:53-60.
60. Basti AA, Razavilar V, Abbasifar R, Radmehr B, Misaghi A, Khalighi Sigaroodi F. Effect of Zataria multiflora Boiss essential oil on probability of growth initiation of Salmonella typhimurium in a brain heart infusion broth. J Med Plants 2004;3:85-92.
61. Shafiee A, Javidnia K, Tabatabai M. Volatile constituents and antimicrobial activity of Zataria multiflora, population Iran. Irn J Chem Chem Eng 1999;18:1-5.
62. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004;50:81-92.
63. Kiyohara H, Matsumoto T, Yamada H. Combination effects of herbs in a multi-herbal formula: expression of Juzen-taiho-to's immuno-modulatory activity on the intestinal immune system. Evid Based Complement Alternat Med 2004;1:83-91.
64. Hadjibabaie M, Rastkari N, Rezaie A, Abdollahi M. The adverse drug reaction in the gastrointestinal tract: an overview. Intl J Pharmacol 2005;1:1-8.